Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
FLUENT Expands Hyer Kind Brand to the New York Market
NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a national cannabis company operating under the FLUENT™ brand, is proud to announce the launch of Hyer Kind, a cosmic voyage into the world of premium cannabis, in the state of New York. Hyer Kind's expertly crafted live rosin-infused pre-rolls “Boosters” are now available at all adult-use FLUENT retail stores throughout New York and its rapidly growing wholesale channels statewide.» Mehr auf globenewswire.com
Undervalued U.S. Cannabis Penny Stocks to Add to Your Watchlist
The U.S. cannabis industry continues to grow rapidly, creating opportunities for investors focused on penny stocks. In 2024, legal cannabis sales topped $32 billion nationwide. That number is expected to reach $45 billion by the end of 2025. This growth is fueled by new state-level legalization and rising consumer demand. Currently, adult-use cannabis is legal in nearly half the U.S. states. Even more importantly, recent headlines hint at changes at the federal level. A proposal to reclassify marijuana under federal law could ease restrictions on the industry. As a result, many investors are turning their attention to low-priced marijuana stocks. These companies often react quickly to news and momentum, offering big upside potential. However, it's critical to approach these trades with the right tools and awareness.» Mehr auf marijuanastocks.com
3 Marijuana Stocks To Keep On Watch After Q4 Earnings
Marijuana stocks are still having issues catching bigger waves of momentum. Even with most cannabis companies reporting strong Q4 earnings it only did so much for the public sector. Many feel as more reform and regulatory issues are met in favor of legal operators it will help the public sector. The biggest fight for legal cannabis is better laws in place that help legal operators, not just corporate cannabis. There are many parts to what makes a strong industry and a solid company.» Mehr auf marijuanastocks.com
Unternehmenszahlen
(EUR) | Sep. 2024 | |
---|---|---|
Umsatz | 23,48 Mio | - |
Bruttoeinkommen | 10,40 Mio | - |
Nettoeinkommen | −10,58 Mio | - |
EBITDA | 4,18 Mio | - |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 33,71 Mio€ |
Anzahl Aktien | 636,96 Mio |
52 Wochen-Hoch/Tief | 0,23€ - 0,0438€ |
Dividenden | Nein |
Beta | 3,06 |
KGV (PE Ratio) | −0,78 |
KGWV (PEG Ratio) | 0,01 |
KBV (PB Ratio) | −3,03 |
KUV (PS Ratio) | 0,35 |
Unternehmensprofil
Cansortium Inc. produziert und vertreibt über seine Tochtergesellschaften medizinisches Cannabis in den Vereinigten Staaten. Das Unternehmen ist in den Bereichen Anbau, Verarbeitung, Einzelhandel und Vertrieb tätig. Seine medizinischen Cannabisprodukte werden in Form von oralen Tropfen, Kapseln, Zäpfchen, topischen Produkten, Spritzen, getrockneten Blüten, Prerolls, Patronen und Esswaren angeboten. Das Unternehmen bietet seine Produkte unter dem Markennamen Fluent an. Mit Stand vom 20. August 2021 betrieb es 28 Apotheken. Cansortium Inc. wurde im Jahr 2018 gegründet und hat seinen Hauptsitz in Miami, Florida.
Name | CANSORTIUM INC. Aktie |
CEO | Robert Beasley |
Sitz | Miami, fl USA |
Website | |
Börsengang | |
Mitarbeiter | 0 |
Ticker Symbole
Börse | Symbol |
---|---|
Pnk | CNTMF |
Frankfurt | 2WM.F |
Assets entdecken
Shareholder von CANSORTIUM INC. Aktie investieren auch in folgende Assets